312 related articles for article (PubMed ID: 25795420)
1. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
[TBL] [Abstract][Full Text] [Related]
2. Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics.
Finco D; Baltrukonis D; Clements-Egan A; Delaria K; Gunn GR; Lowe J; Maia M; Wong T
J Pharm Biomed Anal; 2011 Jan; 54(2):351-8. PubMed ID: 20863644
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
[TBL] [Abstract][Full Text] [Related]
4. Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.
Ferguson J; Bird C; Wadhwa M; Burns C
J Immunol Methods; 2013 Jan; 387(1-2):191-8. PubMed ID: 23142458
[TBL] [Abstract][Full Text] [Related]
5. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
Wei X; Swanson SJ; Gupta S
J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
[TBL] [Abstract][Full Text] [Related]
7. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
Chen XC; Zhou L; Gupta S; Civoli F
J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody.
Xiang Y; Parng C; Olson K; Seletskaia E; Gorovits B; Jani D; Caiazzo T; Joyce A; Donley J
AAPS J; 2019 Mar; 21(3):46. PubMed ID: 30927117
[TBL] [Abstract][Full Text] [Related]
9. Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay.
Wu Y; Akhgar A; Li JJ; Yu B; Chen C; Lee N; White WI; Roskos LK
AAPS J; 2018 Mar; 20(3):49. PubMed ID: 29541868
[TBL] [Abstract][Full Text] [Related]
10. Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serum.
Sanchez S; Barger T; Zhou L; Hale M; Mytych D; Gupta S; Swanson SJ; Civoli F
J Pharm Biomed Anal; 2011 Jul; 55(5):1265-74. PubMed ID: 21497040
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Cludts I; Meager A; Thorpe R; Wadhwa M
J Immunol Methods; 2013 Sep; 395(1-2):37-44. PubMed ID: 23831137
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
[TBL] [Abstract][Full Text] [Related]
13. Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive
Kruzik A; Koppensteiner H; Fetahagic D; Hartlieb B; Dorn S; Romeder-Finger S; Coulibaly S; Weber A; Hoellriegl W; Horling FM; Scheiflinger F; Reipert BM; de la Rosa M
Hum Gene Ther Methods; 2019 Apr; 30(2):35-43. PubMed ID: 30734588
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of cell-based assays for the detection of neutralizing antibodies to drug products: a practical approach.
Jolicoeur P; Tacey RL
Bioanalysis; 2012 Dec; 4(24):2959-70. PubMed ID: 23244285
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the first WHO Erythropoietin antibody reference panel: Report of an international collaborative study.
Wadhwa M; Mytych DT; Bird C; Barger T; Dougall T; Han H; Rigsby P; Kromminga A; Thorpe R;
J Immunol Methods; 2016 Aug; 435():32-42. PubMed ID: 27173074
[TBL] [Abstract][Full Text] [Related]
16. Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay.
Schwickart M; Mehrzai F; Pearson J; Shaghasi N; Chavez C; Schneider A; Wu S; Roskos L; Liang M
J Immunol Methods; 2014 Jan; 403(1-2):52-61. PubMed ID: 24287421
[TBL] [Abstract][Full Text] [Related]
17. Indirect assessment of neutralizing anti-drug antibodies utilizing pharmacokinetic assay data.
Vettermann C; Ortiz J; Lee S; Sanchez S; Victor HP; Ma M; Heath T; Gupta S
J Immunol Methods; 2016 Feb; 429():28-38. PubMed ID: 26711311
[TBL] [Abstract][Full Text] [Related]
18. Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics.
Wu B; Chung S; Jiang XR; McNally J; Pedras-Vasconcelos J; Pillutla R; White JT; Xu Y; Gupta S
AAPS J; 2016 Nov; 18(6):1335-1350. PubMed ID: 27495119
[TBL] [Abstract][Full Text] [Related]
19. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).
Liao K; Sikkema D; Wang C; Lee TN
J Immunol Methods; 2013 Mar; 389(1-2):52-60. PubMed ID: 23298658
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.
Gupta S; Devanarayan V; Finco D; Gunn GR; Kirshner S; Richards S; Rup B; Song A; Subramanyam M
J Pharm Biomed Anal; 2011 Jul; 55(5):878-88. PubMed ID: 21531522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
